ReviewFrontiers in cellular and infection microbiology2022

Targeting bacterial pathogenesis by inhibiting virulence-associated Type III and Type IV secretion systems.

Nadja Blasey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.